BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37244570)

  • 1. Loss of Residues 119-136, Including the First β-strand of Human Prion Protein, Generates an Aggregation-competent Partially "Open" Form.
    Hosszu LLP; Sangar D; Batchelor M; Risse E; Hounslow AM; Collinge J; Waltho JP; Bieschke J
    J Mol Biol; 2023 Aug; 435(15):168158. PubMed ID: 37244570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A valine-to-lysine substitution at position 210 induces structural conversion of prion protein into a β-sheet rich oligomer.
    Kakuda K; Yamaguchi KI; Kuwata K; Honda R
    Biochem Biophys Res Commun; 2018 Nov; 506(1):81-86. PubMed ID: 30336980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residue-specific mobility changes in soluble oligomers of the prion protein define regions involved in aggregation.
    Glaves JP; Ladner-Keay CL; Bjorndahl TC; Wishart DS; Sykes BD
    Biochim Biophys Acta Proteins Proteom; 2018 Sep; 1866(9):982-988. PubMed ID: 29935976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Structural Characterization of the Precursor Conformation of the Prion Protein which Directly Initiates Misfolding and Oligomerization.
    Moulick R; Udgaonkar JB
    J Mol Biol; 2017 Mar; 429(6):886-899. PubMed ID: 28147229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Method for Folding of Recombinant Prion Protein to Soluble β-Sheet Secondary Structure.
    Ellett LJ
    Methods Mol Biol; 2017; 1658():23-26. PubMed ID: 28861779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Terminal Regions of Prion Protein: Functions and Roles in Prion Diseases.
    Hara H; Sakaguchi S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissection of conformational conversion events during prion amyloid fibril formation using hydrogen exchange and mass spectrometry.
    Singh J; Udgaonkar JB
    J Mol Biol; 2013 Sep; 425(18):3510-21. PubMed ID: 23811055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of Unfolding of Human Prion Protein.
    Singh RK; Chamachi NG; Chakrabarty S; Mukherjee A
    J Phys Chem B; 2017 Jan; 121(3):550-564. PubMed ID: 28030950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates.
    Sneideris T; Ziaunys M; Chu BK; Chen RP; Smirnovas V
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pH and aggregation in the human prion conversion into scrapie form: a study using molecular dynamics with excited normal modes.
    Lima AN; de Oliveira RJ; Braz ASK; de Souza Costa MG; Perahia D; Scott LPB
    Eur Biophys J; 2018 Jul; 47(5):583-590. PubMed ID: 29546436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of N-glycosylation site variants during human PrP aggregation and fibril nucleation.
    Mishra R; Elgland M; Begum A; Fyrner T; Konradsson P; Nyström S; Hammarström P
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):909-921. PubMed ID: 30935958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disassociation of β1-α1-β2 from the α2-α3 domain of prion protein (PrP) is a prerequisite for the conformational conversion of PrP
    Chandrasekaran P; Santosh Kumar C; Rangachari K; Sekar K
    Int J Biol Macromol; 2019 Sep; 136():368-376. PubMed ID: 31207327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation-Dependent Refolding of Prion Protein Unveils Amyloidogenic-Related Structural Ramifications: Insights from Molecular Dynamics Simulations.
    Palaniappan C; Narayanan RC; Sekar K
    ACS Chem Neurosci; 2021 Aug; 12(15):2810-2819. PubMed ID: 34296847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of misfolding of the human prion protein revealed by a pathological mutation.
    Sanz-Hernández M; Barritt JD; Sobek J; Hornemann S; Aguzzi A; De Simone A
    Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33731477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the propensities of helices in PrP(C) to form beta sheet using NMR structures and sequence alignments.
    Dima RI; Thirumalai D
    Biophys J; 2002 Sep; 83(3):1268-80. PubMed ID: 12202354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolutionarily Conserved Proline Residues Impede the Misfolding of the Mouse Prion Protein by Destabilizing an Aggregation-competent Partially Unfolded Form.
    Pal S; Udgaonkar JB
    J Mol Biol; 2022 Dec; 434(23):167854. PubMed ID: 36228749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methionine oxidation perturbs the structural core of the prion protein and suggests a generic misfolding pathway.
    Younan ND; Nadal RC; Davies P; Brown DR; Viles JH
    J Biol Chem; 2012 Aug; 287(34):28263-75. PubMed ID: 22654104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid fibrils from the N-terminal prion protein fragment are infectious.
    Choi JK; Cali I; Surewicz K; Kong Q; Gambetti P; Surewicz WK
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13851-13856. PubMed ID: 27849581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The polybasic N-terminal region of the prion protein controls the physical properties of both the cellular and fibrillar forms of PrP.
    Ostapchenko VG; Makarava N; Savtchenko R; Baskakov IV
    J Mol Biol; 2008 Nov; 383(5):1210-24. PubMed ID: 18789949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion protein amyloid formation under native-like conditions involves refolding of the C-terminal alpha-helical domain.
    Cobb NJ; Apetri AC; Surewicz WK
    J Biol Chem; 2008 Dec; 283(50):34704-11. PubMed ID: 18930924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.